Cempra

Cempra

closed
Cempra develops innovative antibiotics to address critical unmet medical needs. Their two lead products, currently in clinical development, target drug-resistant bacterial infections in both hospital and community settings.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR20152016
R&D budget61.0m60.0m

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$22.0m

Series A
N/A

$10.0m

Series B
N/A

$46.0m

Series C
N/A

N/A

IPO
N/A

$25.1m

Post IPO Equity
Total FundingAUD121m

Recent News about Cempra

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Cempra

Edit
Melinta
ACQUISITION by Cempra Aug 2017